Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Axitinib Monotherapy With Early Dynamic Contrast Enhanced Ultrasound Monitoring in Chemorefractory Third Line Metastatic Colorectal Cancer

ABSTRACT: This is a study of Axitinib versus placebo as monotherapy for people with colorectal cancer who have liver metastases and who have relapsed within 6 months of their last chemotherapy regime. The research will also look at the potential of CEHPI (Contrast Enhanced Hepatic Perfusion Index) reduction, a technique developed for this research to measure the changes in how the blood vessels pump blood into the different liver metastases (tumours) and therefore to assess and predict response to treatment.

DISEASE(S): Rectum,Colorectal Cancer,Colorectal Neoplasms,Third Line Colorectal Liver Metastases

PROVIDER: 2336681 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Single cell RNA-seq of 4T1 mammary tumors treated with Axitinib

Project description:To understand the effect of hypoxia on vasculogenic mimicry we treated mammary tumour dervied from parental 4T1 cells with vehicle or Axitinib. Tumors were analyzed by scRNA-seq and the expression of endothelial genes assessed in these data with and wihtout Axitinib treatment.

2023-07-26 | GSE230641 | GEO

Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation

Project description:Here we report that Axitinib, an inhibitor of VEGFRs currently in use as a second line treatment for advanced renal cell carcinoma, promotes senescence of human endothelial cells in vitro. Mechanistically, this requires oxidative stress-dependent activation of the Ataxia Telangiectasia Mutated (ATM) kinase. Induction of oxidative stress-related genes distinguishes the response of endothelial cells to Axitinib from that to doxorubicin

2019-07-02 | GSE126426 | GEO

Assessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal Cancer

Project description:The purpose of this study is to evaluate and quantify the dynamic modifications of tumor blood perfusion on axitinib therapy in patients with refractory mCRC for each dose of Axitinib.

| 2116784 | ecrin-mdr-crc

Gene expression changes in mouse breast cancer cells (4T1) after axitinib resistance

Project description:RNA sequencing analysis was used to identify changes in mouse breast cancer cells (4T1) resistant to axitinib (AxR).

2019-06-12 | GSE132568 | GEO

Gene expression changes in mouse breast cancer cells (4T1) after axitinib resistance and FACS isolation of SA-β-galHi (SM+) and SA-β-galLo (SM-) cells

Project description:RNA sequencing analysis was used to identify changes in mouse breast cancer cells (4T1) after axitinib resistance and FACS isolation of SA-β-galHi (SM+) and SA-β-galLo (SM-) cells

2024-08-01 | GSE226243 | GEO

Proteome and Phosphoproteome of colorectal cancer liver metastases (CRLM), phosphoproteomics of AZD6482 treated CRC cell lines, phosphoproteomics of copanlisib treated xenograft

Project description:The research focuses on the longitudinal analysis of phosphoproteomic profiles in patients with recurrent colorectal liver metastases. Twenty-four individuals who underwent initial and recurrent resections for colorectal liver metastases participated in the study. Tissue samples were systematically collected throughout the treatment period from the liver metastases and normal liver tissue of each of the 24 patients at two timepoints. To validate the therapeutic candidate, we conducted a phosphoproteomics analysis of cell lines treated with AZD6482 and xenograft samples treated with copanlisib. The analysis aimed to assess the pharmacological effects of these treatments.

2025-01-30 | PXD048988 | JPOST Repository

Single cell RNA-seq of 4T1 mammary tumors treated with Axitinib

Project description:Single cell RNA-seq of 4T1 mammary tumors treated with Axitinib

| PRJNA962042 | ENA

Axitinib as Maintenance Treatment in Patients With Metastatic CRC

Project description:The purpose of this study is to evaluate the maintenance therapy with axitinib in patients with metastatic colorectal carcinoma

| 2116583 | ecrin-mdr-crc

Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation

Project description:Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation

| PRJNA521866 | ENA

Gene expression changes in mouse breast cancer cells (4T1) after axitinib resistance

Project description:Gene expression changes in mouse breast cancer cells (4T1) after axitinib resistance

| PRJNA548373 | ENA